1Mendelsohn J. The epidermal growth factor receptor as a target for cancer therapy. Endocr Relat Cancer, 2001, 8( 1 ) : 3-9.
2Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys, 2004, 59(Suppl) : 21-26.
3Raben D, Bianco C, Milas L, et al. Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress? Semin in Radiat Oncol, 2004, 14(2): 139-152.
4Herbst RS, Langer C J, Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancer. Semin Oncol, 2002, 29( 1 Suppl 4) :27-36.
5Barker FG 2nd, Simmons ML, Chang SM, et al. EGFR overexpression and radiation response in glioblastoma multiforme. Int J Radiat Oncol Biol Phys, 2001,51(2): 410-418.
6Ang KK, Berkey BA, Tu X, el al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advancedhead and neck carcinoma. Cancer Res, 2002,62(24):7350-7356.
7Harari PM, Huang S. Radiation combined with EGFR signal inhibitors:head and neck cancer focus. Semin Radiat Oncol,2006,16( 1 ) :38-40.
8Liang K, Ang KK, Milas L, et al. The epidermal growth factor receptor mediates radioresistanee, Int J Radiat Oacol Biol Phys, 2003, 57( 1 ) : 246-254.
9Milas L, Mason KA, Ang KK. Epidermal growth factor receptor and its inhibition in radiotherapy: in vivo findings. Int J Radiat Biol, 2003,79(7) : 539-545.
10Milas L, Akimoto T, Hunter NR, et al. Relationship between Cyclin DI expression and poor radioresponse of routine carcinomas. Int J Radiat Oneol Biol Phys,2002,52(2) :514-521.
7Fukutome M, Maebayashi K, Nasu S, et al. Enhancement of radiosensitivily by dual inhibition of the HER family with ZD1839 ("Iressa") and trastuzumab("Herceptin"). Int J Radiat Oncol Biol Phys, 2006, 66(2): 528-536.
8Sarkaria JN, Carlson BL, Schreeder MA, et al. Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response. Clin Cancer Res, 2006, 12 (7 Pt 1): 2264-2271.
